Related references
Note: Only part of the references are listed.Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
Tian Chuan et al.
MEDICAL SCIENCE MONITOR (2020)
Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression
Naofumi Mukaida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
Aeri Aotsuka et al.
CANCER SCIENCE (2019)
High A20 expression negatively impacts survival in patients with breast cancer
Chang Ik Yoon et al.
PLOS ONE (2019)
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
F. Amicarella et al.
GUT (2017)
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
Yun-Feng Ma et al.
ONCOTARGET (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients
Shreyas Bhat et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers
Francois Bertucci et al.
ONCOIMMUNOLOGY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker
Lei Guo et al.
SPRINGERPLUS (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis
Annica Andersson et al.
CLINICAL IMMUNOLOGY (2015)
Inflammatory breast cancer: An overview
D. J. P. van Uden et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Itay Raphael et al.
CYTOKINE (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
Basic biology and role of interleukin-17 in immunity and inflammation
Camille Zenobia et al.
PERIODONTOLOGY 2000 (2015)
Prognostic and predictive value of PDL1 expression in breast cancer
Renaud Sabatier et al.
ONCOTARGET (2015)
Th17 Cell Plasticity and Functions in Cancer Immunity
Leslie Guery et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
Minoru Miyashita et al.
BREAST CANCER RESEARCH (2015)
Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
Zonglin Chen et al.
PLOS ONE (2014)
IL-17 family: Cytokines, receptors and signaling
Chunfang Gu et al.
CYTOKINE (2013)
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor
Wen-Chung Chen et al.
HISTOPATHOLOGY (2013)
The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
Abhishek V. Garg et al.
SCIENCE SIGNALING (2013)
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2
Stephanie Cochaud et al.
SCIENTIFIC REPORTS (2013)
Expression of Th17 Cells in Breast Cancer Tissue and Its Association with Clinical Parameters
LiJuan Yang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner
Carl J. DeSelm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer
Jiu-Wei Du et al.
MOLECULAR MEDICINE REPORTS (2012)
Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25
Bo Zhong et al.
NATURE IMMUNOLOGY (2012)
Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis
Abdul M. Tyagi et al.
PLOS ONE (2012)
CD8(+) lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
Shuzhen Liu et al.
BREAST CANCER RESEARCH (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
IL-17F: Regulation, signaling and function in inflammation
Seon Hee Chang et al.
CYTOKINE (2009)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
XingWu Zhu et al.
BREAST CANCER RESEARCH (2008)
IL-25 regulates Th17 function in autoimmune inflammation
Melanie A. Kleinschek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction
R Schwandner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
